IDEXX Laboratories Total Non-Operating Income/Expense 2010-2025 | IDXX
IDEXX Laboratories annual/quarterly total non-operating income/expense history and growth rate from 2010 to 2025. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
- IDEXX Laboratories total non-operating income/expense for the quarter ending March 31, 2025 was $-0.006B, a 85.4% increase year-over-year.
- IDEXX Laboratories total non-operating income/expense for the twelve months ending March 31, 2025 was $-0.021B, a 19.62% decline year-over-year.
- IDEXX Laboratories annual total non-operating income/expense for 2024 was $-0.019B, a 48.53% decline from 2023.
- IDEXX Laboratories annual total non-operating income/expense for 2023 was $-0.036B, a 7.32% decline from 2022.
- IDEXX Laboratories annual total non-operating income/expense for 2022 was $-0.039B, a 32.07% increase from 2021.
| IDEXX Laboratories Annual Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2024 | $-19 |
| 2023 | $-36 |
| 2022 | $-39 |
| 2021 | $-29 |
| 2020 | $-33 |
| 2019 | $-31 |
| 2018 | $-34 |
| 2017 | $-32 |
| 2016 | $-28 |
| 2015 | $-27 |
| 2014 | $-14 |
| 2013 | $-4 |
| 2012 | $-2 |
| 2011 | $-2 |
| 2010 | $-2 |
| 2009 | $-1 |
| IDEXX Laboratories Quarterly Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-6 |
| 2024-12-31 | $-5 |
| 2024-09-30 | $-5 |
| 2024-06-30 | $-5 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $-6 |
| 2023-09-30 | $-7 |
| 2023-06-30 | $-10 |
| 2023-03-31 | $-13 |
| 2022-12-31 | $-13 |
| 2022-09-30 | $-11 |
| 2022-06-30 | $-8 |
| 2022-03-31 | $-7 |
| 2021-12-31 | $-7 |
| 2021-09-30 | $-7 |
| 2021-06-30 | $-8 |
| 2021-03-31 | $-8 |
| 2020-12-31 | $-8 |
| 2020-09-30 | $-8 |
| 2020-06-30 | $-9 |
| 2020-03-31 | $-8 |
| 2019-12-31 | $-7 |
| 2019-09-30 | $-7 |
| 2019-06-30 | $-8 |
| 2019-03-31 | $-8 |
| 2018-12-31 | $-8 |
| 2018-09-30 | $-8 |
| 2018-06-30 | $-8 |
| 2018-03-31 | $-9 |
| 2017-12-31 | $-8 |
| 2017-09-30 | $-8 |
| 2017-06-30 | $-8 |
| 2017-03-31 | $-8 |
| 2016-12-31 | $-7 |
| 2016-09-30 | $-7 |
| 2016-06-30 | $-7 |
| 2016-03-31 | $-7 |
| 2015-12-31 | $-7 |
| 2015-09-30 | $-7 |
| 2015-06-30 | $-7 |
| 2015-03-31 | $-6 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $-4 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $-2 |
| 2013-12-31 | $-1 |
| 2013-09-30 | $-1 |
| 2013-06-30 | $-1 |
| 2013-03-31 | $0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $-1 |
| 2011-12-31 | $-1 |
| 2011-09-30 | $0 |
| 2011-06-30 | $0 |
| 2011-03-31 | $0 |
| 2010-12-31 | $0 |
| 2010-09-30 | $-1 |
| 2010-06-30 | $-1 |
| 2010-03-31 | $0 |
| 2009-12-31 | $0 |
| 2009-09-30 | $0 |
| 2009-06-30 | $0 |
| 2009-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $38.097B | $3.898B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $190.127B | 83.28 |
| Thermo Fisher Scientific (TMO) | United States | $153.648B | 18.58 |
| Alcon (ALC) | Switzerland | $47.347B | 31.47 |
| Edwards Lifesciences (EW) | United States | $44.043B | 28.82 |
| DexCom (DXCM) | United States | $31.969B | 49.41 |
| IQVIA Holdings (IQV) | United States | $25.777B | 14.17 |
| Mettler-Toledo (MTD) | United States | $22.100B | 26.28 |
| STERIS (STE) | Ireland | $21.856B | 24.99 |
| Waters (WAT) | United States | $20.170B | 28.47 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.308B | 0.00 |
| Hologic (HOLX) | United States | $11.835B | 12.86 |
| Sysmex ADR (SSMXY) | Japan | $11.715B | 0.00 |
| Penumbra (PEN) | United States | $11.306B | 88.74 |
| Globus Medical (GMED) | United States | $9.687B | 22.43 |
| Masimo (MASI) | United States | $8.725B | 32.29 |
| Teleflex (TFX) | United States | $5.328B | 8.79 |
| Glaukos (GKOS) | United States | $4.983B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.125B | 21.61 |
| TransMedics (TMDX) | United States | $3.159B | 92.46 |
| PROCEPT BioRobotics (PRCT) | United States | $2.945B | 0.00 |
| Veracyte (VCYT) | United States | $2.393B | 43.04 |
| LivaNova (LIVN) | United Kingdom | $1.917B | 11.60 |
| Elekta AB (EKTAY) | Sweden | $1.889B | 16.98 |
| Nihon Kohden (NHNKY) | Japan | $1.867B | 10.21 |
| Alphatec Holdings (ATEC) | United States | $1.779B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.420B | 0.00 |
| Artivion (AORT) | United States | $1.171B | 109.68 |
| Pulse Biosciences (PLSE) | United States | $1.113B | 0.00 |
| OPKO Health (OPK) | United States | $1.015B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.991B | 5.27 |
| AxoGen (AXGN) | United States | $0.747B | 0.00 |
| SiBone (SIBN) | United States | $0.700B | 0.00 |
| IRadimed (IRMD) | United States | $0.649B | 32.92 |
| Mesa Laboratories (MLAB) | United States | $0.641B | 14.01 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.591B | 9.24 |
| RxSight (RXST) | United States | $0.567B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.492B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.471B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.464B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| NeuroPace (NPCE) | United States | $0.383B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.367B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.350B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.318B | 6.74 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.94 |
| CVRx (CVRX) | United States | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| 908 Devices (MASS) | United States | $0.190B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.182B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.145B | 0.00 |
| Accuray (ARAY) | United States | $0.134B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.130B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.098B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.077B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.070B | 10.60 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.054B | 0.00 |
| Hyperfine (HYPR) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.66 |